IngredientsButter is a dairy product consisting primarily of milk fat derived from bovine (Bos taurus) or, less commonly, ovine, caprine, or buffalo milk. It has no single botanical name, as it is an animal-derived emulsified fat rather than a plant-based ingredient. The product is governed by international compositional standards: according to the Codex Alimentarius (2018), butter must contain a minimum of 80% milk fat, a maximum of 16% water, and no more than 2% non-fat milk solids.
At the mechanistic level, butter is a water-in-oil emulsion produced by churning cream until the milk fat separates from the liquid buttermilk. Milk fat, which is 97 to 98% triacylglycerols, is a source of energy and nutrients and an important food ingredient that provides desirable textural and flavor characteristics.
Butter appears commercially and domestically in several distinct forms:
The earliest evidence of milk use dates back to around 6,500 BCE. A team led by Richard Evershed, a biogeochemist at the University of Bristol, discovered residues of milk fats on pottery found in Northwest Turkey. It is believed that raw milk wasn't actually consumed by people at this time due to uniform lactose intolerance in adults. The high amounts of milk fats found in the pottery suggest that people ate butter, cheese and yogurt, rather than consuming raw milk.
A Sumerian tablet from ancient Mesopotamia that dates back to 2,500 BCE illustrates rudimentary dairy production. The tablet depicts the milking of cows, and consequently, the making of butter. The discovery process is believed to have been accidental: ancient peoples likely stumbled upon butter while transporting milk in animal skins, which would agitate the liquid through movement. This agitation caused the milk's fat molecules to clump together, eventually separating from the buttermilk.
Ancient cultures around the world used butter as a sacred tool for their spiritual practices. This goes back to the Sumerians 2,500 B.C., and the Vedic Aryans, the Druids, the Hindus, and the Buddhists.
Like other ancient civilizations, Egyptians used butter in religious ceremonies, and some tomb paintings even depict butter-making. In the Indian subcontinent, India's warm climate encouraged the use of ghee, a type of clarified butter that resists spoilage. Ghee, made by simmering butter to remove water and milk solids, became a staple ingredient. In Vedic culture, ghee was considered sacred and used in religious rituals and ceremonies. Known in Ayurveda as "Ghrita" in Sanskrit, ghee is one of the most sacred and healing foods described by the ancient Ayurvedic texts. It is made by a simple process of gently simmering cultured butter to remove potential allergens such as casein and lactose. What remains is the pure delicious butter oil, described as conferring good health and longevity.
In ancient Greece and Rome, attitudes toward butter were more ambivalent. The ancient Greeks and Romans seemed to use the butter only as unguent and medicine and considered it as a food of the barbarians. A play by the Greek comic poet Anaxandrides refers to Thracians as boutyrophagoi, "butter-eaters". In his Natural History, Pliny the Elder calls butter "the most delicate of food among barbarous nations" and goes on to describe its medicinal properties. Later, the physician Galen also described butter as a medicinal agent only. Romans used butter for cosmetic purposes and also as a healing balm, often sneaking tiny licks in between applications on their wounds.
Hippocrates, the famous Greek physician, mentioned butter in his writings and recommended it for medicinal purposes, including treating skin ailments and digestive issues.
In the cooler climates of northern Europe, butter could be stored longer before it spoiled. In Ireland, butter dating back 5,000 years has been found preserved in peat bogs. The use of the churn, a traditional butter-making tool, existed in Scotland since the 6th century AD and became widespread by the 13th century.
Butter rose to prominence in the Middle Ages, when it became a commonly-used product throughout northern Europe. Though the upper classes considered it peasant food, they also ate it periodically. Back then, the consumption of butter was prohibited during Lent. Many people in northern Europe chose to pay the fee imposed by the Catholic church that allowed them to eat butter.
During the Middle Ages, butter production shifted from families to monasteries, where it was produced on a large scale.
In ancient India, clarified butter, known as "ghee," was and remains a key ingredient in Ayurvedic cooking and medicine. Ayurvedic uses traditionally included cooking, rituals, and panchakarma; ghee may support digestion, ojas (nourishing essence), and the mobilization of lipophilic toxins during cleansing. Ghee is sweet, cooling and pacifies Vata and Pitta. It can be recommended in food, therapeutically by itself, in formulations, or as an Anupaan (medium in which formulations are given). It is often used during cleansing and detoxification and various other Ayurvedic therapies.
Milk fat is the dominant component of butter, and it is one of the most complex dietary fats found in nature. Butter contains over 400 different fatty acids, making its fat profile far more varied than most plant-based oils or animal fats.
The fatty acid composition of milk fat typically comprises 70% saturated fatty acids, 25% monounsaturated fatty acids, and 5% polyunsaturated fatty acids. The most abundant fatty acid in butter is palmitic acid (C16:0), followed by myristic (C14:0), stearic (C18:0), and oleic acid (C18:1n9).
The exact fatty acid distribution shows notable quantitative ranges. Fatty acid composition analysis showed variations, with palmitic acid ranging from 26.11% to 44.25%, oleic acid from 19.55% to 29.80%, and linoleic acid from 1.63% to 3.04%.
The most significant polyunsaturated fatty acids in butter are linoleic acid (an omega-6 fatty acid) and alpha-linolenic acid (an omega-3 fatty acid). Both are classified as essential fatty acids because the human body cannot synthesize them on its own; they must come from the diet.
One of the most biologically noteworthy short-chain fatty acids in butter is butyric acid. Butter is notable for its rich composition of fatty acids, cholesterol, tocopherol, and aroma components. It contains over 400 different fatty acids with varied biological and nutritional properties essential for human health, along with significant levels of cholesterol and tocopherol. Butyric acid is a short-chain saturated fatty acid and a primary energy substrate for colonocytes (colonic epithelial cells). Butyrate has different mechanisms of action, including strong regulatory effects on the expression of many genes by inhibiting the histone deacetylases and modulating cellular metabolism.
Conjugated linoleic acid (CLA) is a naturally occurring polyunsaturated fatty acid found in the milk fat and meat of ruminant animals. Butter is one of the richest dietary sources of CLA, with the cis-9, trans-11 isomer making up 80–90% of the total CLA content in dairy fat. This particular isomer has been the focus of extensive research for its potential health benefits.
Grass-fed production substantially alters CLA concentration. Numerous analyses have shown that butter from exclusively grass-fed or pastured cows is higher in omega-3 fats, conjugated linoleic acid (CLA), and beta-carotene than that from cows on grain-based rations.
Butter naturally contains a small amount of trans fat — roughly 3% of total fat. However, the predominant trans fat in butter is vaccenic acid, which is produced naturally during digestion in ruminant animals. This is different from industrial trans fats found in hydrogenated vegetable oils.
Butter provides a small amount of fat-soluble vitamins A, E, and K. The fatty acid and nutrient composition of butter varies depending on a cow's diet. Cholesterol contents ranged from 134.13 to 325 mg/100 g, α-tocopherol contents ranged from 1.62 to 3.37 mg/100 g, and β-carotene contents ranged from 4.46 to 15.60 μg/g across studied samples. Traditional butter showed higher α-tocopherol and β-carotene contents than commercial samples.
Grass-fed butter is believed to be much richer in vitamin K2, which plays an important role in bone and heart health.
Cholesterol, a critical component of cell membranes and a precursor for bile acids and steroid hormones, plays a significant role in butter's nutritional profile.
Ovine milk fat products had higher short- and medium-chain saturated fatty acid (SFA) content, while samples made with bovine milk fat had higher long-chain SFA content. Differences in the fatty acid and triglyceride contents of butter as a result of lactation and dietary effects demonstrated significant correlations with the hardness, rheological, melting, and crystallization profiles of the butters.
Butyrate has different mechanisms of action, including strong regulatory effects on the expression of many genes by inhibiting the histone deacetylases and modulating cellular metabolism. Butyric acid can influence the composition of the microbial community by elevating butyrate levels and promoting the growth of beneficial bacteria, including Lactobacillus, Bifidobacterium, and Ruminococcus. Furthermore, butyric acid inhibits HDAC, promotes forkhead box protein P3 (FOXP3) expression and Treg cell differentiation, thus lowering the risk of immune diseases in children.
High dietary saturated fat intake is associated with higher blood concentrations of low-density lipoprotein cholesterol (LDL-C), an established risk factor for coronary heart disease. The specific chain lengths of individual fatty acids in butter differ in their metabolic impacts: the chain length of individual saturated fatty acids (SFAs) and their formulation within the food matrix likely influences their metabolic actions and subsequent health effects.
CLA has been associated with improved insulin sensitivity, reduced body fat, and anti-inflammatory effects. Animal and cell studies have proposed several mechanistic pathways, including modulation of lipid metabolism and cell proliferation. However, as detailed in the clinical evidence section below, human evidence for these effects remains mixed.
Systematic review evidence: In a systematic review and meta-analysis of prospective studies, researchers found a small positive association between butter consumption and all-cause mortality, no significant association with incident CVD or CVD subtypes, and a modest inverse association with type 2 diabetes. Because several of the identified reports included multiple country-specific cohorts, the total numbers of nation-specific cohorts, participants, and clinical events appear reasonably robust. Together, these studies included more than 28,000 total deaths, nearly 10,000 cases of incident CVD, and nearly 24,000 cases of incident diabetes.
The quantified per-serving association with mortality was very small: butter consumption was weakly associated with all-cause mortality (N=9 country-specific cohorts; per 14 g (1 tablespoon)/day: RR=1.01, 95% CI=1.00, 1.03, P=0.045); was not significantly associated with any CVD (N=4; RR=1.00, 95% CI=0.98, 1.02; P=0.79).
The overall conclusion of this meta-analysis was that these findings do not support a need for major emphasis in dietary guidelines on either increasing or decreasing butter consumption, in comparison to other better established dietary priorities; while also highlighting the need for additional investigation of health and metabolic effects of butter and dairy fat. In summary, these findings suggest relatively small or neutral associations of butter consumption with long-term health.
Evidence strength: Moderate. The evidence base is predominantly observational (prospective cohorts). No RCTs of butter intake were identified in the literature search. Observational studies are subject to residual confounding (dietary patterns, socioeconomic factors), limiting causal inference.
The COB Trial (Cambridge, UK, 2018): Participants were randomized to extra virgin coconut oil, extra virgin olive oil or unsalted butter and asked to consume 50 g daily of one of these fats for 4 weeks. LDL-C concentrations were significantly increased on butter compared with coconut oil (+0.42, 95% CI 0.19 to 0.65 mmol/L, P<0.0001) and with olive oil (+0.38, 95% CI 0.16 to 0.60 mmol/L, P<0.0001). Butter significantly increased TC/HDL-C ratio and non-HDL-C compared with coconut oil.
Secondary fatty acid analyses from the same trial confirmed that the consumption of extra-virgin coconut oil, rich in lauric acid (C12:0), a medium-chain SFA, led to significantly decreased low-density lipoprotein cholesterol (LDL-C) and increased high-density lipoprotein cholesterol (HDL-C) as compared with butter consumption, rich in long-chain palmitic (C16:0) and stearic (C18:0) SFAs.
Evidence strength: The COB trial was a well-designed RCT but was short-term (4 weeks), used a high dose (50 g/day), and the population (mean age 60 years, 67% women, 98% European Caucasian) may not be broadly generalizable. Lipid changes are surrogate markers, and the trial was not powered for clinical cardiovascular endpoints.
A systematic review of RCTs conducted for the 2025 Dietary Guidelines Advisory Committee found that twelve articles (21 comparisons) examined replacing butter with plant-based oils and spreads by adults and older adults on LDL-C, HDL-C and triglyceride levels. All were randomized controlled trials. The direction and effect size of results were similar across studies, suggesting consistent LDL-raising effects of butter relative to plant-based alternatives.
Butyric acid, produced by gut microbiota fermentation, has gained significant attention over the past decade. It shows strong therapeutic potential in both experimental and clinical treatments for inflammatory diseases across multiple systems. As a dietary source of butyric acid, butter directly provides this short-chain fatty acid to the gut lumen.
In the context of inflammatory bowel disease, most preclinical and clinical studies have shown the positive effect of butyrate oral supplements in reducing inflammation and maintaining remission in colitis animal models and IBD patients. However, butyrate enema showed mixed effects. The current literature suggests that butyrate is a potential add-on therapy to reduce inflammation and maintain IBD remission. Further clinical studies are needed to determine if butyrate administration alone is an effective therapeutic treatment for IBD.
Regarding liver health, increasing evidence suggests that butyrate could be helpful in the prevention of liver diseases and metabolism regulation. It ameliorates metabolic diseases, including insulin resistance and obesity, and plays a direct role in preventing fatty liver diseases.
Evidence strength: Preliminary to moderate. Most human evidence for butyrate relates to supplemental butyrate formulations — not specifically to dietary butter as the butyrate source. Much of the mechanistic evidence is from in vitro and animal studies. The clinical translation of dietary butter's butyric acid content to systemic effects has not been established in controlled human trials.
CLA has been identified as a potent anti-carcinogenic agent in animal studies. Research notes that CLA can inhibit new tumor growth and destroy existing cancer cells across several types, including colon, ovarian, prostate, and breast cancers. In one landmark study, CLA-enriched butter fat reduced mammary tumor incidence by 53% in rats, clearly demonstrating the anti-cancer potential of the cis-9, trans-11 isomer.
However, CLA has demonstrated promising anticancer effects in animal and test-tube studies, though more research is needed. Animal and test-tube studies suggest that CLA may help prevent certain chronic diseases, such as type 2 diabetes, heart disease, and even certain cancers. However, human-research findings are mixed.
Regarding body composition, studies show that CLA may help fight obesity. Research suggests that the CLA found in this type of butter may help you lose weight and cut body fat in some people.
Evidence strength: Weak to preliminary for human outcomes. Most compelling data come from animal models. Human RCT evidence for CLA from dietary butter specifically (rather than concentrated CLA supplements) is very limited. Conclusions about cancer prevention in humans cannot be drawn from current data.
The Cochrane systematic review on reducing saturated fat for cardiovascular disease (Hooper et al., 2020) identified butter as one of the major dietary sources of saturated fat: practical ways to achieve reductions in dietary saturated fat include switching to lower fat dairy foods and cutting off meat fats, as well as reducing intake of foods high in saturated fats such as cakes, biscuits, pies and pastries, butter, ghee, lard, palm oil, sausages and cured meats, hard cheese, cream, ice cream, milkshakes and chocolate. Reducing saturated fat reduces serum cholesterol, but effects on other intermediate outcomes may be less clear.
Evidence strength: Moderate. Replacing saturated fats (including those from butter) with unsaturated fats consistently reduces LDL cholesterol in trials, but the magnitude of clinical cardiovascular benefit remains debated and context-dependent.
Butter is consumed as a food rather than a concentrated supplement, and "dosages" in research contexts reflect dietary intake levels. The following specific amounts are reported in identified sources:
No specific therapeutic dosage for butter as a dietary supplement is established in the peer-reviewed clinical literature. Dosages used in studies investigating butter's bioactive constituents (e.g., CLA or butyrate) typically involve isolated or concentrated forms of those compounds rather than butter itself as a supplement vehicle.
Butter retains milk proteins, including casein and whey. Individuals with a true IgE-mediated milk allergy face risk of allergic reactions from butter consumption. For those with a severe dairy allergy, it is recommended to avoid all forms of dairy, including ghee. This is because trace amounts of milk proteins may still remain in ghee, which can trigger an allergic reaction.
Regular butter contains very small residual amounts of lactose and is generally tolerated by most lactose-intolerant individuals at typical serving sizes. Ghee and clarified butter undergo a process that removes most lactose: ghee is made by a simple process of gently simmering cultured butter to remove potential allergens such as casein and lactose. The absence of lactose and casein (protein) is what makes ghee suitable for people who cannot digest dairy (lactose intolerant). However, ghee is suitable for individuals with lactose intolerance as the clarifying process removes most of the lactose and casein. However, those with severe dairy allergies should exercise caution.
As documented in controlled trials, consuming butter in large quantities (e.g., 50 g/day in the COB trial) significantly raises LDL-C compared with olive oil and coconut oil. High dietary saturated fat intake is associated with higher blood concentrations of LDL-C, an established risk factor for coronary heart disease. Individuals with pre-existing hyperlipidemia should be aware that high butter intake may further elevate LDL-C.
Oxidation is the most important factor limiting the shelf life of butter. The oxidation of butter causes a rancid taste and unpleasant odour, significant reductions in quality, and rejection by the consumer. Toxic reaction products form in the latter stages of lipid oxidation. Oxidized flavor occurs when milk fat reacts with oxygen, producing compounds that taste stale, cardboard-like, or metallic. This reaction is triggered by exposure to air and light, and is accelerated by the presence of dissolved metals such as copper in the cream. Once initiated, oxidation can continue as a chain reaction even when butter is stored in the dark, because it involves free radical cascades that propagate on their own once started.
Regarding cholesterol oxidation products specifically, storage at -18°C almost prevented cholesterol oxidation (approximately 4 µg/g milk lipid) in dairy spreads. To prevent rancidity, butter should be protected from heat, light and air by storing it covered in the refrigerator.
The nutritional and safety profile of butter is not uniform. Traditional butter samples exhibited differences in aroma components and fatty acid composition compared to commercial butter. Grass-fed versus grain-fed production significantly alters fatty acid composition, CLA content, and fat-soluble vitamin levels. Consumers seeking specific nutrient targets (e.g., higher CLA or vitamin K2) should be aware that these vary substantially depending on animal diet and processing method.
Traditional Ayurvedic medicine specifies conditions under which ghee is contraindicated. Ghee should not be consumed by individuals with unbalanced Kapha or Ama (except for Shatpala Ghritam), hepatitis, fatty liver, congestion, fever, obesity, indigestion, and/or diarrhea — reflecting a traditional, not pharmacologically validated, framework.
Health conditions that Butter may help support.
Body systems that Butter may help support.
Go back